These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 27147296

  • 1. Characterization of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line.
    Earnest-Silveira L, Chua B, Chin R, Christiansen D, Johnson D, Herrmann S, Ralph SA, Vercauteren K, Mesalam A, Meuleman P, Das S, Boo I, Drummer H, Bock CT, Gowans EJ, Jackson DC, Torresi J.
    J Gen Virol; 2016 Aug; 97(8):1865-1876. PubMed ID: 27147296
    [Abstract] [Full Text] [Related]

  • 2. Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice.
    Huret C, Desjardins D, Miyalou M, Levacher B, Amadoudji Zin M, Bonduelle O, Combadière B, Dalba C, Klatzmann D, Bellier B.
    Vaccine; 2013 Mar 01; 31(11):1540-7. PubMed ID: 22634300
    [Abstract] [Full Text] [Related]

  • 3. Antibody Responses to a Quadrivalent Hepatitis C Viral-Like Particle Vaccine Adjuvanted with Toll-Like Receptor 2 Agonists.
    Christiansen D, Earnest-Silveira L, Chua B, Boo I, Drummer HE, Grubor-Bauk B, Gowans EJ, Jackson DC, Torresi J.
    Viral Immunol; 2018 May 01; 31(4):338-343. PubMed ID: 29489437
    [Abstract] [Full Text] [Related]

  • 4. Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine.
    Christiansen D, Earnest-Silveira L, Chua B, Meuleman P, Boo I, Grubor-Bauk B, Jackson DC, Keck ZY, Foung SKH, Drummer HE, Gowans EJ, Torresi J.
    Sci Rep; 2018 Apr 24; 8(1):6483. PubMed ID: 29691437
    [Abstract] [Full Text] [Related]

  • 5. Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.
    Chmielewska AM, Naddeo M, Capone S, Ammendola V, Hu K, Meredith L, Verhoye L, Rychlowska M, Rappuoli R, Ulmer JB, Colloca S, Nicosia A, Cortese R, Leroux-Roels G, Balfe P, Bienkowska-Szewczyk K, Meuleman P, McKeating JA, Folgori A.
    J Virol; 2014 May 24; 88(10):5502-10. PubMed ID: 24599994
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. N-glycosylation-mutated HCV envelope glycoprotein complex enhances antigen-presenting activity and cellular and neutralizing antibody responses.
    Ren Y, Min YQ, Liu M, Chi L, Zhao P, Zhang XL.
    Biochim Biophys Acta; 2016 Aug 24; 1860(8):1764-75. PubMed ID: 26278021
    [Abstract] [Full Text] [Related]

  • 9. Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy.
    Kumar A, Das S, Mullick R, Lahiri P, Tatineni R, Goswami D, Bhat P, Torresi J, Gowans EJ, Karande AA, Das S.
    Vaccine; 2016 Feb 17; 34(8):1115-25. PubMed ID: 26700891
    [Abstract] [Full Text] [Related]

  • 10. Recombinant hepatitis C virus-like particles expressed by baculovirus: utility in cell-binding and antibody detection assays.
    Xiang J, Wünschmann S, George SL, Klinzman D, Schmidt WN, LaBrecque DR, Stapleton JT.
    J Med Virol; 2002 Dec 17; 68(4):537-43. PubMed ID: 12376962
    [Abstract] [Full Text] [Related]

  • 11. Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice.
    Cao J, Chen Z, Ren Y, Luo Y, Cao M, Lu W, Zhao P, Qi Z.
    Vaccine; 2011 May 09; 29(20):3714-23. PubMed ID: 21396407
    [Abstract] [Full Text] [Related]

  • 12. A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice.
    Masavuli MG, Wijesundara DK, Underwood A, Christiansen D, Earnest-Silveira L, Bull R, Torresi J, Gowans EJ, Grubor-Bauk B.
    Front Immunol; 2019 May 09; 10():1145. PubMed ID: 31178869
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R, Li G, Ling S, Zhang H, Yao Z, Xiu B, He F, Huang R, Wei L.
    Antiviral Res; 2009 Oct 09; 84(1):23-30. PubMed ID: 19646486
    [Abstract] [Full Text] [Related]

  • 19. Identification of a novel epitope in the C terminus of hepatitis C virus-E2 protein that induces potent and cross-reactive neutralizing antibodies.
    Das S, Mullick R, Kumar A, Tandon H, Bose M, Gouthamchandra K, Chandra M, Ravishankar B, Khaja MN, Srinivasan N, Das S, Melkote Subbarao S, Karande AA.
    J Gen Virol; 2017 May 09; 98(5):962-976. PubMed ID: 28221101
    [Abstract] [Full Text] [Related]

  • 20. A simple method to purify recombinant HCV core protein expressed in Pichia pastoris for obtaining virus-like particles and producing monoclonal antibodies.
    Pechelyulko A, Andreeva-Kovalevskaya Z, Dmitriev D, Lavrov V, Massino Y, Nagel A, Segal O, Sokolova OS, Solonin A, Tarakanova Y, Dmitriev A.
    Protein Expr Purif; 2021 Jul 09; 183():105864. PubMed ID: 33677084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.